Skip to main content
NCBI home page
Neural Regeneration Research logoLink to Neural Regeneration Research
. 2019 Oct;14(10):1765–1771. doi: 10.4103/1673-5374.257540

TrkA regulates the regenerative capacity of bone marrow stromal stem cells in nerve grafts

Mei-Ge Zheng 1,2,#, Wen-Yuan Sui 1,#, Zhen-Dan He 3, Yan Liu 4, Yu-Lin Huang 1, Shu-Hua Mu 5, Xin-Zhong Xu 2, Ji-Sen Zhang 2, Jun-Le Qu 6, Jian Zhang 3,*, Dong Wang 1,*
PMCID: PMC6585565  PMID: 31169194

graphic file with name NRR-14-1765-g001.jpg

Keywords: nerve regeneration, bone marrow stromal stem cells, tropomyosin receptor kinase A receptor, lentiviral vector, shRNA, extracellular signal-regulated protein kinases 1/2, Bcl-2, nerve grafts, peripheral nerve regeneration, survival, neural regeneration

Abstract

We previously demonstrated that overexpression of tropomyosin receptor kinase A (TrkA) promotes the survival and Schwann cell-like differentiation of bone marrow stromal stem cells in nerve grafts, thereby enhancing the regeneration and functional recovery of the peripheral nerve. In the present study, we investigated the molecular mechanisms underlying the neuroprotective effects of TrkA in bone marrow stromal stem cells seeded into nerve grafts. Bone marrow stromal stem cells from Sprague-Dawley rats were infected with recombinant lentivirus vector expressing rat TrkA, TrkA-shRNA or the respective control. The cells were then seeded into allogeneic rat acellular nerve allografts for bridging a 1-cm right sciatic nerve defect. Then, 8 weeks after surgery, hematoxylin and eosin staining showed that compared with the control groups, the cells and fibers in the TrkA overexpressing group were more densely and uniformly arranged, whereas they were relatively sparse and arranged in a disordered manner in the TrkA-shRNA group. Western blot assay showed that compared with the control groups, the TrkA overexpressing group had higher expression of the myelin marker, myelin basic protein and the axonal marker neurofilament 200. The TrkA overexpressing group also had higher levels of various signaling molecules, including TrkA, pTrkA (Tyr490), extracellular signal-regulated kinases 1/2 (Erk1/2), pErk1/2 (Thr202/Tyr204), and the anti-apoptotic proteins Bcl-2 and Bcl-xL. In contrast, these proteins were downregulated, while the pro-apoptotic factors Bax and Bad were upregulated, in the TrkA-shRNA group. The levels of the TrkA effectors Akt and pAkt (Ser473) were not different among the groups. These results suggest that TrkA enhances the survival and regenerative capacity of bone marrow stromal stem cells through upregulation of the Erk/Bcl-2 pathway. All procedures were approved by the Animal Ethical and Welfare Committee of Shenzhen University, China in December 2014 (approval No. AEWC-2014-001219).

Chinese Library Classification No. R4543; R364

Introduction

Mesenchymal stem cells, such as bone marrow stromal stem cells (BMSCs) and adipose-derived stem cells, are an ideal autologous stem cell source for repairing nerve injuries because of their numerous attractive properties, including easy isolation, immunomodulatory ability, the production of trophic factors, and neural plasticity (Oliveira et al., 2013; Masgutov et al., 2016, 2018; Jiang et al., 2017). A recent study showed that neither BMSCs nor adipose-derived stem cells within venous grafts provide satisfactory results for peripheral nerve repair (Fernandes et al., 2018), suggesting that further optimization of tissue-engineered nerve grafts is needed. A number of studies have shown that BMSC-seeded acellular nerve grafts effectively improve neural regeneration and functional recovery after peripheral nerve injuries (Hu et al., 2007; Wang et al., 2008, 2010, 2012; Jia et al., 2012, 2017; Pang et al., 2013; Zhao et al., 2014; Zheng et al., 2017), depending on the density and viability of BMSCs in nerve grafts (Raheja et al., 2012; Zheng et al., 2016; Hou et al., 2018).

Tropomyosin receptor kinase A (TrkA) is the high affinity membrane-bound receptor for nerve growth factor (NGF), and mediates multiple effects, including neuronal survival and differentiation, and nerve growth and regeneration (Huang and Reichardt, 2001; Marlin and Li, 2015). Previous studies show that TrkA is markedly upregulated during the differentiation of BMSCs into neurons (Woodbury et al., 2000; Yaghoobi and Mowla, 2006; Li et al., 2007; Jian et al., 2015). Upon NGF binding to TrkA, the phosphatidylinositol-3 kinase/Akt and Ras/extracellular signal-regulated kinase (Erk) signaling pathways are activated and facilitate axonal outgrowth, branching, elongation and maintenance during the regeneration of peripheral nerves (Auer et al., 2012; Klimaschewski et al., 2013; Chan et al., 2014; Xing et al., 2016; Huang et al., 2017). Accordingly, we hypothesized that TrkA might be a key regulator of BMSC function in nerve grafts. To test this hypothesis, we overexpressed or knocked-down TrkA in BMSCs and then seeded these cells into rat sciatic nerve defects in a previous study (Zheng et al., 2016). We found that TrkA overexpression promoted the survival and Schwann cell-like differentiation of BMSCs in nerve grafts (Zheng et al., 2016), and stimulated the ability of these cells to enhance peripheral nerve regeneration and functional recovery (Zheng et al., 2017). In the present study, we investigated the molecular mechanisms underlying this process.

Materials and Methods

Animals

Thirty adult specific-pathogen-free male Sprague-Dawley rats, 7–8 weeks of age and weighing 200–250 g, were obtained from Guangdong Medical Laboratory Animal Center, China (license No. SCXK (Yue) 2013-0002). Rats were housed in temperature- and humidity-controlled specific-pathogen-free animal rooms with a 12/12-hour light/dark cycle and fed standard lab chow and water ad libitum. All surgical procedures were performed under general anesthesia with a dosage of 0.4 mL/100 g body weight via intraperitoneal injection of 2% pentobarbital sodium (Sigma-Aldrich, St. Louis, MO, USA). All procedures were approved by the Animal Ethical and Welfare Committee of Shenzhen University, China in December 2014 (approval No. AEWC-2014-001219).

Preparation of TrkA-overexpressing and TrkA-shRNA-expressing BMSCs

BMSCs were harvested from the femurs and tibias of rats (n = 10), which were also used as the source of the allogeneic acellular nerves. The BMSCs were isolated, expanded and identified as previously described (Zheng et al., 2016). Lentiviruses encoding rat TrkA cDNA (Sino Biological, Beijing, China) and shRNA targeting rat TrkA (TrkA-shRNA sequence: 5′-ATT CAG GTG ACT GAG CCG AGG G-3′; product size: 22 bp; Hanbio, Shanghai, China), as well as their respective empty lentiviral controls (Hanbio), were used to infect rat BMSCs at passage 3, according to a previously published protocol (Zheng et al., 2016). Briefly, for lentiviral infection, BMSCs at approximately 60% confluence in 6-well dishes (5 × 105 per well) were treated with the lentivirus-containing medium (multiplicity of infection = 15) combined with polybrene (5 μg/mL; Hanbio). After 24 hours, the culture medium was replaced with fresh medium. Then, 24 hours later, puromycin (Sigma-Aldrich) was added to the medium at a final concentration of 2 μg/mL. Stably-infected BMSCs were obtained after 3 weeks of antibiotic selection. Uninfected BMSCs were used as negative controls. The following stably-infected BMSCs were obtained: TrkA-overexpressing BMSCs (Over-TrkA BMSCs), TrkA-shRNA expressing BMSCs (TrkA-shRNA BMSCs), and their respective empty vector controls (Vector BMSCs and Control BMSCs).

Preparation of allogeneic acellular nerves

Bilateral sciatic nerves of anesthetized rats (n = 10) were excised and dissected into 15-mm-long nerve segments under sterile conditions. Adipose and connective tissues were removed from the surface of the nerves with the help of a dissecting microscope. The acellular nerves were prepared as described previously (Zheng et al., 2017). Briefly, the nerve segments were sequentially rinsed twice in distilled water, 3% Triton X-100 (Sigma-Aldrich) and 4% sodium deoxycholate (Sigma-Aldrich). Each acellular nerve was trimmed to a 10-mm-long segment and stored in phosphate-buffered saline containing 100 U/mL penicillin and 100 μg/mL streptomycin (Hyclone, Thermo Fisher Scientific, Waltham, MA, USA) at 4°C. Storage buffer was replaced every week. Hematoxylin and eosin staining was used to assess the effects of the chemical extraction treatments on the nerves as described below.

In vitro construction of tissue-engineered nerves

Tissue-engineered nerve grafts were constructed by seeding the stably-infected BMSCs into the allogeneic acellular nerves. The 10-mm-long acellular nerves were pre-incubated in cell culture medium at 37°C for 3 hours. BMSCs for graft seeding were labeled with PKH26 (Sigma-Aldrich) according to the manufacturer’s instructions. A single-cell suspension of BMSCs in 2% gelatin (Sigma-Aldrich), a relatively inert material for preventing cell leakage (Chen et al., 2007; Jia et al., 2012) was prepared at 2 × 107 cells/mL. A total of 2 × 105 BMSCs in 10 µL cell suspension was injected into an acellular nerve graft in equal volumes at four evenly-spaced points using a microinjector. The nerve grafts implanted with the infected BMSCs were then incubated in low-glucose Dulbecco’s modified Eagle’s medium (Gibco, Thermo Fisher Scientific) containing 10% fetal bovine serum (Hyclone, Thermo Fisher Scientific), 100 U/mL penicillin and 100 μg/mL streptomycin at 37°C, 5% CO2 under humidified conditions for 48 hours until the in vivo transplantation was performed. The fluorescent signals of PKH26-labeled BMSCs in the nerve grafts were detected on an inverted fluorescence microscope (IX71, Olympus, Tokyo, Japan) before transplantation.

In vivo transplantation of BMSC-containing nerve grafts

Twenty adult male rats were randomly divided into the following four groups (n = 5 per group): Over-TrkA BMSC-seeded nerve grafts (over-TrkA group), vector BMSC-seeded nerve grafts (vector group), TrkA-shRNA BMSC-seeded nerve grafts (TrkA-shRNA group) and control BMSC-seeded nerve grafts (control group). As described previously (Zheng et al., 2017), the right sciatic nerve was exposed through an incision in the muscle under anesthesia. A 10-mm-long nerve segment distal to the sciatic notch was dissected. The tissue-engineered nerve graft was then attached with 10-0 nylon interrupted epineurial sutures to the proximal and distal stumps of the sciatic nerve to bridge the 10-mm gap. The incision was closed in layers with 3-0 nylon sutures, and the rats were left to convalesce for 8 weeks after surgery.

Hematoxylin and eosin staining

Eight weeks after the surgery, rats were anesthetized with pentobarbital sodium, and the 5-mm-long proximal segments of the nerve grafts were harvested and fixed in 4% paraformaldehyde in phosphate-buffered saline overnight at 4°C, as described before (Zheng et al., 2017). The segments were then submerged in 30% sucrose for 24 hours and mounted in optimal cutting temperature compound (Tissue-Tek, Sakura, Tokyo, Japan), and cut into 12-μm-thick frozen serial sections on a cryostat (CM1850; Leica, Wetzlar, Germany). The allogeneic acellular nerves were fixed and prepared in the same manner. Hematoxylin and eosin staining was performed for observing histological changes, and images were acquired with an Eclipse Ni-U microscope with NIS-Elements BR Imaging software (Nikon Instruments, Tokyo, Japan).

Western blot assay

Eight weeks after the surgery, rats were sacrificed under anesthesia. Nerve grafts were harvested and flash frozen in liquid nitrogen. Tissues were homogenized in RIPA buffer (Sigma-Aldrich) supplemented with protease and phosphatase inhibitors (Roche Applied Science, Mannheim, Germany). Protein extracts were centrifuged at 13,201 × g (12,000 rpm) for 30 minutes at 4°C. Protein quantification was performed using the Pierce BCA protein assay kit (Thermo Fisher Scientific). Equal amounts of protein were separated by 10–12% SDS-PAGE, and transferred to polyvinylidene fluoride membranes. The membranes were blocked with 5% non-fat milk or 10% bovine serum albumin in Tris-buffered saline, and immunoblotted with appropriate primary and secondary antibodies. The following antibodies were used: mouse monoclonal anti-glial fibrillary acidic protein (GFAP, Schwann cell marker; 1:1000; Millipore, Darmstadt, Germany), mouse monoclonal anti-neurofilament 200 (NF200, axonal marker; 1:500; Boster, Wuhan, China), rabbit polyclonal anti-myelin basic protein (MBP, myelin marker; 1:500; Boster), rabbit polyclonal anti-TrkA (1:500; Millipore), rabbit polyclonal anti-TrkA phosphorylated at Tyr490 (pTrkA; 1:1000; Cell Signaling Technology, Danvers, MA, USA), rabbit polyclonal anti-Akt (1:1000; Cell Signaling Technology), rabbit polyclonal anti-Akt phosphorylated at Ser473 (pAkt; 1:1000; Cell Signaling Technology), rabbit polyclonal anti-Erk1/2 (1:1000; Cell Signaling Technology), rabbit polyclonal anti-Erk1/2 phosphorylated at Thr202/Tyr204 (pErk1/2; 1:1000; Cell Signaling Technology), rabbit polyclonal anti-Bcl-2 (anti-apoptotic protein; 1:1000; Cell Signaling Technology), rabbit polyclonal anti-Bcl-xL (anti-apoptotic protein; 1:1000; Cell Signaling Technology), rabbit polyclonal anti-Bad (pro-apoptotic factor; 1:1000; Cell Signaling Technology), rabbit polyclonal anti-Bax (pro-apoptotic factor; 1:1000; Cell Signaling Technology), rabbit polyclonal anti-cleaved caspase-3 (apoptotic marker; 1:1000; Cell Signaling Technology) and mouse monoclonal anti-β-actin (1:5000; Sigma-Aldrich). Secondary antibodies included goat polyclonal anti-mouse antibody conjugated with horseradish peroxidase (1:10,000; Sigma-Aldrich) and goat polyclonal anti-rabbit conjugated with horseradish peroxidase (1:10,000; Sigma-Aldrich). Signals were visualized with ECL substrate (Thermo Fisher Scientific) and exposed to autoradiographic film (Eastman Kodak, Rochester, NY, USA). Protein bands were quantified by densitometric analysis and normalized to β-actin as internal control with ImageJ software (National Institutes of Health, Bethesda, MD, USA). Relative protein expression level was calculated as the ratio of the integrated density value of the target protein to that of β-actin.

Statistical analysis

All data are shown as the mean ± SEM. Statistical analyses were performed in GraphPad Prism 5 software (GraphPad, La Jolla, CA, USA). One-way analysis of variance was used to compare mean values, followed by the Student-Newman-Keuls post hoc test. A value of P < 0.05 was considered statistically significant.

Results

Histological examination of acellular nerves before and after BMSC seeding

To evaluate histological changes in the nerve grafts before and after BMSC seeding, hematoxylin and eosin staining was performed. As shown in Figure 1, there was no evidence of visible cells, axons or myelin sheaths in the acellular nerves, while the basal lamina tubes remained structurally intact. In contrast, many blue nuclei, axons and myelin sheaths were visible in the BMSC-containing nerve grafts, suggesting the seeded cells were viable and motile (Figure 1). Compared with the vector and control groups, the cells and fibers were more densely and uniformly arranged in the over-TrkA group, whereas they were distributed more sparsely and in a disorderly manner in the TrkA-shRNA group (Figure 1).

Figure 1.

Figure 1

Open in a new tab

Images of transverse and longitudinal sections of hematoxylin and eosin-stained acellular nerve and nerve grafts from over-TrkA, vector, TrkA-shRNA and control groups 8 weeks after surgery.

The sparse areas devoid of blue nuclei and myelin sheaths are labeled with asterisks. Arrows designate myelinated nerve fibers. Scale bars: 200 µm.

TrkA overexpression increases GFAP, NF200 and MBP expression in BMSC-seeded nerve grafts

We previously showed that TrkA overexpression promotes the Schwann cell-like differentiation of BMSCs, as demonstrated by the colocalization of S100/GFAP and PKH26 (Zheng et al., 2016), and the regeneration of MBP-positive nerve fibers (Zheng et al., 2017). Here, we assessed the protein levels of GFAP, NF200 and MBP in nerve grafts by western blot assay. As shown in Figure 2, the expression levels of GFAP, NF200 and MBP were significantly upregulated in the over-TrkA group (P < 0.001 or P < 0.01), but significantly downregulated in the TrkA-shRNA group (P < 0.01 or P < 0.05), compared with the vector and control groups. These results are consistent with our previous findings (Zheng et al., 2016, 2017) and show that TrkA overexpression enhances the ability of BMSCs to promote peripheral nerve regeneration.

Figure 2.

Figure 2

Open in a new tab

GFAP, NF200 and MBP protein expression in nerve grafts 8 weeks after surgery.

(A) Western blot assay for GFAP, NF200 and MBP in nerve grafts from over-TrkA, vector, TrkA-shRNA and control groups. (B) The bands were quantified by densitometry and normalized to β-actin. Data are expressed as the mean ± SEM (n = 5 per group; one-way analysis of variance followed by Student-Newman-Keuls post hoc test). *P < 0.05, **P < 0.01, ***P < 0.001, vs. vector and control groups. NF200: Neurofilament 200; GFAP: glial fibrillary acidic protein; MBP: myelin basic protein.

TrkA overexpression activates the Erk1/2 pathway in BMSC-seeded nerve grafts

To clarify the role of TrkA in the BMSC-containing nerve grafts, the levels of proteins involved in the TrkA pathway, including TrkA, pTrkA, Akt, pAkt, Erk1/2 and pErk1/2, were evaluated by western blot assay. Compared with the vector and control groups, TrkA and pTrkA levels were significantly higher in the over-TrkA group (P < 0.001 and P < 0.05; Figure 3), whereas they were significantly lower in the TrkA-shRNA group (P < 0.05; Figure 3). However, Akt and pAkt levels were similar among all four groups (Figure 3), suggesting that TrkA overexpression in BMSCs may not affect the Akt pathway. Erk1/2 and pErk1/2 levels were significantly higher in the over-TrkA group (P < 0.01 and P < 0.05; Figure 3), while they were significantly lower in the TrkA-shRNA group (P < 0.01; Figure 3), compared with the vector and control groups. These results suggest that TrkA functions through the Erk1/2 pathway in BMSC-seeded nerve grafts.

Figure 3.

Figure 3

Open in a new tab

Effects of TrkA upregulation and downregulation on the Erk1/2 pathway 8 weeks after surgery.

(A) Western blot assay for TrkA, pTrkA, Akt, pAkt, Erk1/2 and pErk1/2 in nerve grafts from over-TrkA, vector, TrkA-shRNA and control groups. (B) The bands were quantified by densitometry and normalized to β-actin. Data are presented as the mean ± SEM (n = 5 per group; one-way analysis of variance followed by Student-Newman-Keuls post hoc test) *P < 0.05, **P < 0.01, ***P < 0.001, vs. vector and control groups. TrkA: Tropomyosin receptor kinase A; pTrkA: TrkA phosphorylated at Tyr490; pAkt: Akt phosphorylated at Ser473; Erk1/2: extracellular signal-regulated kinases 1/2; pErk1/2: Erk1/2 phosphorylated at Thr202/Tyr204.

TrkA overexpression upregulates Bcl-2 and Bcl-xL in BMSC-containing nerve grafts

To identify downstream effectors in the TrkA–Erk1/2 signaling pathway in nerve grafts, we examined the expression of apoptosis-related proteins. As shown in Figure 4, compared with the vector and control groups, the anti-apoptotic proteins Bcl-2 and Bcl-xL were significantly upregulated in the over-TrkA group (P < 0.001 and P < 0.01). Conversely, their levels were much lower in the TrkA-shRNA group (P < 0.01 and P < 0.001). The expression levels of the pro-apoptotic proteins Bad and Bax and cleaved caspase-3 were significantly higher in the TrkA-shRNA group (P < 0.001), and significantly lower or undetectable in the other three groups. Taken together, these observations suggest that TrkA may induce anti-apoptotic signals and inhibit apoptotic signals, thereby enhancing the survival and function of BMSCs in nerve grafts.

Figure 4.

Figure 4

Open in a new tab

Expression of apoptosis-related proteins in nerve grafts 8 weeks after surgery.

(A) Western blot assay for Bcl-2, Bcl-xL, Bad, Bax and cleaved caspase-3 in nerve grafts from over-TrkA, vector, TrkA-shRNA and control groups. (B) The bands were quantified by densitometry and normalized to β-actin. Data are presented as the mean ± SEM (n = 5 per group; one-way analysis of variance followed by Student-Newman-Keuls post hoc test). **P < 0.01, ***P < 0.001, vs. vector and control groups. Bcl-xL: B-cell lymphoma-extra large; Bcl-2: B-cell lymphoma 2; Bad: Bcl-2-associated death promoter; Bax: Bcl-2-associated X protein; C-caspase-3: cleaved caspase-3.

Discussion

The transmembrane protein TrkA is a high-affinity functional receptor for NGF. The NGF homodimer binds to the extracellular domain of TrkA, causing receptor dimerization and autophosphorylation. Phosphorylation at Tyr490 in the juxtamembrane domain recruits the adapter proteins Shc and Frs2, which activate the phosphatidylinositol-3 kinase/Akt and Ras-Erk1/2 pathways. The signals are conveyed to the nucleus, where they regulate the expression of downstream targets, such as the Bcl-2 family, thereby promoting the survival and differentiation of neurons (Patapoutian and Reichardt, 2001; Marlin and Li, 2015). The Akt and Erk1/2 pathways are necessary for axon sprouting during peripheral nerve regeneration (Okada et al., 2010; Yu et al., 2015; Gaesser and Fyffe-Maricich, 2016). The Erk1/2 pathway regulates neuronal survival and axonal elongation and maintenance after injury (Waetzig and Herdegen, 2005; Seo et al., 2009; Tsuda et al., 2011), whereas the Akt pathway regulates cytoskeletal proteins and axon branching (Markus et al., 2002; Christie et al., 2010; Klimaschewski et al., 2013).

Our previous studies showed that TrkA regulates the survival and Schwann cell-like differentiation of BMSCs in nerve grafts and promotes the repair and regeneration of peripheral nerves (Zheng et al., 2016; Zheng et al., 2017). In the present study, we investigated the underlying molecular mechanisms. Our findings show that the expression levels of the Schwann cell marker GFAP and of axonal regrowth-related proteins NF200 and MBP paralleled TrkA expression. They increased when TrkA was overexpressed and decreased when TrkA expression was silenced. These results are in line with our previous findings, and show that TrkA overexpression robustly promotes the differentiation of BMSCs into Schwann-like cells in nerve grafts and promotes the regeneration of peripheral nerves.

We also found that TrkA overexpression and downregulation affects the levels of pTrkA, Erk1/2, pErk1/2 and other related proteins, while Akt and pAkt did not. Thus, TrkA overexpression in BMSCs seeded into nerve grafts mainly activates the Erk1/2 pathway without affecting the Akt pathway. Because the Erk1/2 pathway regulates neuronal survival and axonal regrowth, extension and maintenance after injury, TrkA overexpression may enhance regeneration by activating the Erk1/2 pathway. However, the functions of the Erk1/2 and Akt pathways in our model remain unclear. Inhibitors of Erk1/2 (U0126) and Akt (LY294002) phosphorylation may help clarify their roles, and will be considered for future studies.

The NGF/TrkA signaling pathway promotes neuronal survival and differentiation by regulating Bcl-2 expression (Orike et al., 2001; Patapoutian and Reichardt, 2001; Liang et al., 2003). During embryonic development, Bcl-2 is widely expressed in the nervous system (Abe-Dohmae et al., 1993; Opferman and Kothari, 2018), and plays a key role in axonal growth and regeneration (Chen et al., 1997). Bcl-2 expression in the adult central nervous system declines with age, but remains widely expressed in the peripheral nervous system (Merry et al., 1994). This suggests that in addition to promoting neuronal survival and differentiation, Bcl-2 may also play an important role in the maintenance of peripheral nerve function. Indeed, the repair and regeneration of peripheral nerves are severely impaired in the absence of Bcl-2 (Kotulska et al., 2003, 2005). This is in line with our current findings that overexpression or downregulation of TrkA in nerve grafts affects the expression of Bcl-2 and Bcl-xL. Previous reports that Bcl-2 overexpression enhances cellular survival but fails to promote axonal regeneration might be due to an unfavorable microenvironment and the specific cell types used (Inoue et al., 2002; Sole et al., 2004; Ghoumari et al., 2005; Leaver et al., 2006). Bcl-2 appears to promote axonal regeneration by enhancing intracellular Ca2+ signaling and by activating CREB and Erk. In contrast, Bcl-xL does not activate CREB and Erk or support axonal growth (Jiao et al., 2005). Therefore, Bcl-2 may be a key downstream effector of TrkA in BMSCs that stimulates peripheral nerve regeneration.

In summary, we show that TrkA activates the Erk1/2 pathway and upregulates Bcl-2 expression in BMSCs seeded in peripheral nerve grafts. Bcl-2 may promote the survival and Schwann cell-like differentiation of the BMSCs, thereby enhancing peripheral nerve regeneration. Our findings should help in the optimization of BMSCs as seed cells for the clinical treatment of peripheral nerve defects.

Additional file: Open peer review report 1 (114.2KB, pdf) .

OPEN PEER REVIEW REPORT 1
NRR-14-1765_Suppl1.pdf (114.2KB, pdf)

Footnotes

Conflicts of interest: The authors declare that there are no conflicts of interest associated with this manuscript.

Financial support: This work was supported by the National Natural Science Foundation of China, No. 81372041 (to DW), and No. 81801220 (to MGZ). The funding body played no role in the study design, collection, analysis and interpretation of data, in the writing of the paper, or in the decision to submit the paper for publication.

Institutional review board statement: The experiments were approved by the Animal Ethical and Welfare Committee of Shenzhen University, China in December 2014 (approval No. AEWC-2014-001219). The experimental procedure followed the United States National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 9 85-23, revised 1985).

Copyright license agreement: The Copyright License Agreement has been signed by all authors before publication.

Data sharing statement: Datasets analyzed during the current study are available from the corresponding author on reasonable request.

Plagiarism check: Checked twice by iThenticate.

Peer review: Externally peer reviewed.

Open peer reviewer: Giulia Ronchi, Università degli Studi diTorino, Italy.

Funding: This work was supported by the National Natural Science Foundation of China, No. 81372041 (to DW), and No. 81801220 (to MGZ).

P-Reviewer: Ronchi G; C-Editor: Zhao M; S-Editors: Wang J, Li CH; L-Editors: Patel B, Qiu Y, Song LP; T-Editor: Jia Y

References

  • 1.Abe-Dohmae S, Harada N, Yamada K, Tanaka R. Bcl-2 gene is highly expressed during neurogenesis in the central nervous system. Biochem Biophys Res Commun. 1993;191:915–921. doi: 10.1006/bbrc.1993.1304. [DOI] [PubMed] [Google Scholar]
  • 2.Auer M, Schweigreiter R, Hausott B, Thongrong S, Holtje M, Just I, Bandtlow C, Klimaschewski L. Rho-independent stimulation of axon outgrowth and activation of the ERK and Akt signaling pathways by C3 transferase in sensory neurons. Front Cell Neurosci. 2012;6:43. doi: 10.3389/fncel.2012.00043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chan KM, Gordon T, Zochodne DW, Power HA. Improving peripheral nerve regeneration: from molecular mechanisms to potential therapeutic targets. Exp Neurol. 2014;261:826–835. doi: 10.1016/j.expneurol.2014.09.006. [DOI] [PubMed] [Google Scholar]
  • 4.Chen CJ, Ou YC, Liao SL, Chen WY, Chen SY, Wu CW, Wang CC, Wang WY, Huang YS, Hsu SH. Transplantation of bone marrow stromal cells for peripheral nerve repair. Exp Neurol. 2007;204:443–453. doi: 10.1016/j.expneurol.2006.12.004. [DOI] [PubMed] [Google Scholar]
  • 5.Chen DF, Schneider GE, Martinou JC, Tonegawa S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature. 1997;385:434–439. doi: 10.1038/385434a0. [DOI] [PubMed] [Google Scholar]
  • 6.Christie KJ, Webber CA, Martinez JA, Singh B, Zochodne DW. PTEN inhibition to facilitate intrinsic regenerative outgrowth of adult peripheral axons. J Neurosci. 2010;30:9306–9315. doi: 10.1523/JNEUROSCI.6271-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Fernandes M, Valente SG, Sabongi RG, Gomes DSJ, Leite VM, Ulrich H, Nery AA, Da SFM. Bone marrow-derived mesenchymal stem cells versus adipose-derived mesenchymal stem cells for peripheral nerve regeneration. Neural Regen Res. 2018;13:100–104. doi: 10.4103/1673-5374.224378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Gaesser JM, Fyffe-Maricich SL. Intracellular signaling pathway regulation of myelination and remyelination in the CNS. Exp Neurol. 2016;283:501–511. doi: 10.1016/j.expneurol.2016.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ghoumari AM, Wehrle R, Sotelo C, Dusart I. Bcl-2 protection of axotomized Purkinje cells in organotypic culture is age dependent and not associated with an enhancement of axonal regeneration. Prog Brain Res. 2005;148:37–44. doi: 10.1016/S0079-6123(04)48004-2. [DOI] [PubMed] [Google Scholar]
  • 10.Hou B, Cai M, Chen C, Ji W, Ye Z, Ling C, Chen Z, Guo Y. Xenogeneic acellular nerve scaffolds supplemented with autologous bone marrow-derived stem cells promote axonal outgrowth and remyelination but not nerve function. J Biomed Mater Res A. 2018;106:3065–3078. doi: 10.1002/jbm.a.36497. [DOI] [PubMed] [Google Scholar]
  • 11.Hu J, Zhu QT, Liu XL, Xu YB, Zhu JK. Repair of extended peripheral nerve lesions in rhesus monkeys using acellular allogenic nerve grafts implanted with autologous mesenchymal stem cells. Exp Neurol. 2007;204:658–666. doi: 10.1016/j.expneurol.2006.11.018. [DOI] [PubMed] [Google Scholar]
  • 12.Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677–736. doi: 10.1146/annurev.neuro.24.1.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Huang H, Liu H, Yan R, Hu M. PI3K/Akt and ERK/MAPK signaling promote different aspects of neuron survival and axonal regrowth following rat facial nerve axotomy. Neurochem Res. 2017;42:3515–3524. doi: 10.1007/s11064-017-2399-1. [DOI] [PubMed] [Google Scholar]
  • 14.Inoue T, Hosokawa M, Morigiwa K, Ohashi Y, Fukuda Y. Bcl-2 overexpression does not enhance in vivo axonal regeneration of retinal ganglion cells after peripheral nerve transplantation in adult mice. J Neurosci. 2002;22:4468–4477. doi: 10.1523/JNEUROSCI.22-11-04468.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Jia H, Wang Y, Tong XJ, Liu GB, Li Q, Zhang LX, Sun XH. Sciatic nerve repair by acellular nerve xenografts implanted with BMSCs in rats xenograft combined with BMSCs. Synapse. 2012;66:256–269. doi: 10.1002/syn.21508. [DOI] [PubMed] [Google Scholar]
  • 16.Jia H, Wang Y, Wang T, Dong Y, Li WL, Li JP, Ma WZ, Tong XJ, He ZY. Synergistic effects of G-CSF and bone marrow stromal cells on nerve regeneration with acellular nerve xenografts. Synapse. 2017 doi: 10.1002/syn.21974. doi: 10.1002/syn.21974. [DOI] [PubMed] [Google Scholar]
  • 17.Jian Q, Li Y, Yin ZQ. Rat BMSCs initiate retinal endogenous repair through NGF/TrkA signaling. Exp Eye Res. 2015;132:34–47. doi: 10.1016/j.exer.2015.01.008. [DOI] [PubMed] [Google Scholar]
  • 18.Jiang L, Jones S, Jia X. Stem cell transplantation for peripheral nerve regeneration: current options and opportunities. Int J Mol Sci. 2017;18:E94. doi: 10.3390/ijms18010094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Jiao J, Huang X, Feit-Leithman RA, Neve RL, Snider W, Dartt DA, Chen DF. Bcl-2 enhances Ca(2+) signaling to support the intrinsic regenerative capacity of CNS axons. EMBO J. 2005;24:1068–1078. doi: 10.1038/sj.emboj.7600589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Klimaschewski L, Hausott B, Angelov DN. The pros and cons of growth factors and cytokines in peripheral axon regeneration. Int Rev Neurobiol. 2013;108:137–171. doi: 10.1016/B978-0-12-410499-0.00006-X. [DOI] [PubMed] [Google Scholar]
  • 21.Kotulska K, Lewin-Kowalik J, Jaroslaw-Jerzy B, Larysz-Brysz M, Marcol W, Fus Z. Bcl-2 deficiency deprives peripheral nerves of neurotrophic activity against injured optic nerve. J Neurosci Res. 2003;73:846–852. doi: 10.1002/jnr.10708. [DOI] [PubMed] [Google Scholar]
  • 22.Kotulska K, Marcol W, Larysz-Brysz M, Barski JJ, Fus Z, Lewin-Kowalik J. Impaired regeneration of bcl-2-lacking peripheral nerves. Neurol Res. 2005;27:843–849. doi: 10.1179/016164105X48815. [DOI] [PubMed] [Google Scholar]
  • 23.Leaver SG, Cui Q, Bernard O, Harvey AR. Cooperative effects of bcl-2 and AAV-mediated expression of CNTF on retinal ganglion cell survival and axonal regeneration in adult transgenic mice. Eur J Neurosci. 2006;24:3323–3332. doi: 10.1111/j.1460-9568.2006.05230.x. [DOI] [PubMed] [Google Scholar]
  • 24.Li N, Yang H, Lu L, Duan C, Zhao C, Zhao H. Spontaneous expression of neural phenotype and NGF, TrkA, TrkB genes in marrow stromal cells. Biochem Biophys Res Commun. 2007;356:561–568. doi: 10.1016/j.bbrc.2007.03.013. [DOI] [PubMed] [Google Scholar]
  • 25.Liang Y, Mirnics ZK, Yan C, Nylander KD, Schor NF. Bcl-2 mediates induction of neural differentiation. Oncogene. 2003;22:5515–5518. doi: 10.1038/sj.onc.1206844. [DOI] [PubMed] [Google Scholar]
  • 26.Markus A, Zhong J, Snider WD. Raf and akt mediate distinct aspects of sensory axon growth. Neuron. 2002;35:65–76. doi: 10.1016/s0896-6273(02)00752-3. [DOI] [PubMed] [Google Scholar]
  • 27.Marlin MC, Li G. Biogenesis and function of the NGF/TrkA signaling endosome. Int Rev Cell Mol Biol. 2015;314:239–257. doi: 10.1016/bs.ircmb.2014.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Masgutov R, Masgutova G, Mukhametova L, Garanina E, Arkhipova SS, Zakirova E, Mukhamedshina YO, Margarita Z, Gilazieva Z, Syromiatnikova V, Mullakhmetova A, Kadyrova G, Nigmetzyanova M, Mikhail S, Igor P, Yagudin R, Rizvanov A. Allogenic adipose derived stem cells transplantation improved sciatic nerve regeneration in rats: autologous nerve graft model. Front Pharmacol. 2018;9:86. doi: 10.3389/fphar.2018.00086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Masgutov RF, Masgutova GA, Zhuravleva MN, Salafutdinov II, Mukhametshina RT, Mukhamedshina YO, Lima LM, Reis HJ, Kiyasov AP, Palotas A, Rizvanov AA. Human adipose-derived stem cells stimulate neuroregeneration. Clin Exp Med. 2016;16:451–461. doi: 10.1007/s10238-015-0364-3. [DOI] [PubMed] [Google Scholar]
  • 30.Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ. bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development. 1994;120:301–311. doi: 10.1242/dev.120.2.301. [DOI] [PubMed] [Google Scholar]
  • 31.Okada K, Tanaka H, Temporin K, Okamoto M, Kuroda Y, Moritomo H, Murase T, Yoshikawa H. Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model. Exp Neurol. 2010;222:191–203. doi: 10.1016/j.expneurol.2009.12.017. [DOI] [PubMed] [Google Scholar]
  • 32.Oliveira JT, Mostacada K, de Lima S, Martinez AM. Bone marrow mesenchymal stem cell transplantation for improving nerve regeneration. Int Rev Neurobiol. 2013;108:59–77. doi: 10.1016/B978-0-12-410499-0.00003-4. [DOI] [PubMed] [Google Scholar]
  • 33.Opferman JT, Kothari A. Anti-apoptotic BCL-2 family members in development. Cell Death Differ. 2018;25:37–45. doi: 10.1038/cdd.2017.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Orike N, Middleton G, Borthwick E, Buchman V, Cowen T, Davies AM. Role of PI 3-kinase, Akt and Bcl-2-related proteins in sustaining the survival of neurotrophic factor-independent adult sympathetic neurons. J Cell Biol. 2001;154:995–1005. doi: 10.1083/jcb.200101068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Pang CJ, Tong L, Ji LL, Wang ZY, Zhang X, Gao H, Jia H, Zhang LX, Tong XJ. Synergistic effects of ultrashort wave and bone marrow stromal cells on nerve regeneration with acellular nerve allografts. Synapse. 2013;67:637–647. doi: 10.1002/syn.21669. [DOI] [PubMed] [Google Scholar]
  • 36.Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol. 2001;11:272–280. doi: 10.1016/s0959-4388(00)00208-7. [DOI] [PubMed] [Google Scholar]
  • 37.Raheja A, Suri V, Suri A, Sarkar C, Srivastava A, Mohanty S, Jain KG, Sharma MC, Mallick HN, Yadav PK, Kalaivani M, Pandey RM. Dose-dependent facilitation of peripheral nerve regeneration by bone marrow-derived mononuclear cells: a randomized controlled study: laboratory investigation. J Neurosurg. 2012;117:1170–1181. doi: 10.3171/2012.8.JNS111446. [DOI] [PubMed] [Google Scholar]
  • 38.Seo TB, Oh MJ, You BG, Kwon KB, Chang IA, Yoon JH, Lee CY, Namgung U. ERK1/2-mediated Schwann cell proliferation in the regenerating sciatic nerve by treadmill training. J Neurotrauma. 2009;26:1733–1744. doi: 10.1089/neu.2008.0711. [DOI] [PubMed] [Google Scholar]
  • 39.Sole M, Fontana X, Gavin R, Soriano E, Del RJ. Bcl-2 overexpression does not promote axonal regeneration of the entorhino-hippocampal connections in vitro after axotomy. Brain Res. 2004;1020:204–209. doi: 10.1016/j.brainres.2004.05.107. [DOI] [PubMed] [Google Scholar]
  • 40.Tsuda Y, Kanje M, Dahlin LB. Axonal outgrowth is associated with increased ERK 1/2 activation but decreased caspase 3 linked cell death in Schwann cells after immediate nerve repair in rats. BMC Neurosci. 2011;12:12. doi: 10.1186/1471-2202-12-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Waetzig V, Herdegen T. MEKK1 controls neurite regrowth after experimental injury by balancing ERK1/2 and JNK2 signaling. Mol Cell Neurosci. 2005;30:67–78. doi: 10.1016/j.mcn.2005.06.001. [DOI] [PubMed] [Google Scholar]
  • 42.Wang D, Liu XL, Zhu JK, Jiang L, Hu J, Zhang Y, Yang LM, Wang HG, Yi JH. Bridging small-gap peripheral nerve defects using acellular nerve allograft implanted with autologous bone marrow stromal cells in primates. Brain Res. 2008;1188:44–53. doi: 10.1016/j.brainres.2007.09.098. [DOI] [PubMed] [Google Scholar]
  • 43.Wang D, Liu XL, Zhu JK, Hu J, Jiang L, Zhang Y, Yang LM, Wang HG, Zhu QT, Yi JH, Xi TF. Repairing large radial nerve defects by acellular nerve allografts seeded with autologous bone marrow stromal cells in a monkey model. J Neurotrauma. 2010;27:1935–1943. doi: 10.1089/neu.2010.1352. [DOI] [PubMed] [Google Scholar]
  • 44.Wang Y, Jia H, Li WY, Tong XJ, Liu GB, Kang SW. Synergistic effects of bone mesenchymal stem cells and chondroitinase ABC on nerve regeneration after acellular nerve allograft in rats. Cell Mol Neurobiol. 2012;32:361–371. doi: 10.1007/s10571-011-9764-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000;61:364–370. doi: 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
  • 46.Xing L, Larsen RS, Bjorklund GR, Li X, Wu Y, Philpot BD, Snider WD, Newbern JM. Layer specific and general requirements for ERK/MAPK signaling in the developing neocortex. Elife. 2016;5:e11123. doi: 10.7554/eLife.11123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Yaghoobi MM, Mowla SJ. Differential gene expression pattern of neurotrophins and their receptors during neuronal differentiation of rat bone marrow stromal cells. Neurosci Lett. 2006;397:149–154. doi: 10.1016/j.neulet.2005.12.009. [DOI] [PubMed] [Google Scholar]
  • 48.Yu H, Zhu L, Li C, Sha D, Pan H, Wang N, Ma S. ERK1/2 and AKT are vital factors in regulation of the migration of rat Schwann cells. J Vet Med Sci. 2015;77:427–432. doi: 10.1292/jvms.14-0555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Zhao Z, Wang Y, Peng J, Ren Z, Zhang L, Guo Q, Xu W, Lu S. Improvement in nerve regeneration through a decellularized nerve graft by supplementation with bone marrow stromal cells in fibrin. Cell Transplant. 2014;23:97–110. doi: 10.3727/096368912X658845. [DOI] [PubMed] [Google Scholar]
  • 50.Zheng M, Duan J, He Z, Wang Z, Mu S, Zeng Z, Qu J, Zhang J, Wang D. Overexpression of tropomyosin receptor kinase A improves the survival and Schwann-like cell differentiation of bone marrow stromal cells in nerve grafts for bridging rat sciatic nerve defects. Cytotherapy. 2016;18:1256–1269. doi: 10.1016/j.jcyt.2016.06.015. [DOI] [PubMed] [Google Scholar]
  • 51.Zheng M, Duan J, He Z, Wang Z, Mu S, Zeng Z, Qu J, Wang D, Zhang J. Transplantation of bone marrow stromal stem cells overexpressing tropomyosin receptor kinase A for peripheral nerve repair. Cytotherapy. 2017;19:916–926. doi: 10.1016/j.jcyt.2017.04.007. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

OPEN PEER REVIEW REPORT 1
NRR-14-1765_Suppl1.pdf (114.2KB, pdf)

Articles from Neural Regeneration Research are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES